Floor Backes

Floor Backes is a gynecologic oncologist who has contributed to clinical trial development and outcomes research for uterine carcinosarcoma, contributing to NRG Oncology studies evaluating carboplatin-paclitaxel as a preferred regimen over ifosfamide-based chemotherapy due to superior tolerability with maintained efficacy. She has published on patterns of recurrence in carcinosarcoma, the role of surgical staging including lymphadenectomy, and the impact of molecular subtype on outcomes. She participates in carcinosarcoma-specific arms of umbrella gynecologic oncology trials.